DELL vs DHR: Which Is the Better Buy?
Side-by-side comparison of Dell Technologies Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Dell Technologies Inc. · Technology
$569.00
-32.5% upside to fair value
Low Conviction
Grade C
VS
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DELL |
DHR |
| Current Price |
$569.00 |
$221.12 |
| Fair Value Estimate |
$383.93 |
$286.52 |
| Upside to Fair Value |
-32.5%
|
+29.6%
|
| Market Cap |
$378.0B |
$155.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
21.8x
|
24.8x
|
| Price / Sales |
2.5x
|
6.2x
|
| Price / FCF |
42.9x
|
28.5x
|
| Revenue Growth YoY |
+57.7%
|
+5.5%
|
| Gross Margin |
19.8%
|
58.5%
|
| Operating Margin |
9.6%
|
20.4%
|
| Return on Equity |
-574.6%
|
7.7%
|
| Dividend Yield |
0.41% |
0.65% |
| FCF Yield |
2.33%
|
3.51%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Dell Technologies is a $378 billion market-cap computer hardware vendor spanning Infrastructure Solutions Group (servers, storage, networking), Client Solutions Group (PCs, displays, peripherals), and a VMware-related software franchise, led by founder-CEO Michael Dell. The business is fundamentally low-quality on the numbers: TTM gross margin is 19.8%, operating margin 9.6%, and net margin 7.5%,…
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Accumulation Zones
| Metric |
DELL |
DHR |
| Zone Low |
$287.95 |
$214.89 |
| Zone High |
$326.34 |
$243.54 |
| In Buy Zone? |
No
|
Yes
|